ChapmanARYerkeJRLumpkinM, et al. Evaluation of response to high-dose intravenous vitamin K administration [published online ahead of print February 20, 2023]. Ann Pharmacother. doi:10.1177/10600280231154246.
2.
BoschJThabutDAlbillosA, et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology. 2008;47(5):1604-1614. doi:10.1002/hep.22216.
3.
Al SulaimanKAl MutairiMAl HarbiO, et al. Appropriateness of using vitamin K for the correction of INR elevation secondary to hepatic disease in critically ill patients: an observational study. Clin Appl Thromb Hemost. 2021;27:10760296211050923. doi:10.1177/10760296211050923.
4.
NanchalRSubramanianRKarvellasCJ, et al. Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU: cardiovascular, endocrine, hematologic, pulmonary and renal considerations: executive summary. Crit Care Med. 2020;48(3):415-419. doi:10.1097/CCM.0000000000004193.
5.
TripodiASalernoFChantarangkulV, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005;41(3):553-558. doi:10.1002/hep.20569.
6.
DabbaghOOzaAPrakashS, et al. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest. 2010;137(5):1145-1149. doi:10.1378/chest.09-2177.
7.
Llibre-NietoGLiraAVergaraM, et al. Micronutrient deficiencies in patients with decompensated liver cirrhosis. Nutrients. 2021;13(4):1249. doi:10.3390/nu13041249.
